| Original language | English |
|---|---|
| Pages (from-to) | 1405-1407 |
| Number of pages | 3 |
| Journal | Journal of Diabetes Investigation |
| Volume | 10 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 01-11-2019 |
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Dietary recommendations for type 2 diabetes patients : Lessons from recent clinical and basic research in Asia. / Seino, Yusuke; Ueno, Shinji; Yabe, Daisuke; Suzuki, Atsushi.
In: Journal of Diabetes Investigation, Vol. 10, No. 6, 01.11.2019, p. 1405-1407.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Dietary recommendations for type 2 diabetes patients
T2 - Lessons from recent clinical and basic research in Asia
AU - Seino, Yusuke
AU - Ueno, Shinji
AU - Yabe, Daisuke
AU - Suzuki, Atsushi
N1 - Funding Information: YS received a scholarship grant from Grants‐in‐Aid for Scientific Research from Japan Society for the Promotion of Science (17k09823), Suzuken Memorial Foundation, Novo Nordisk Pharma Ltd., MSD K.K., Pfizer., Mitsubishi Tanabe Pharma., Eli Lilly and Company., Novartis Pharma., and Daiichi Sankyo Company Ltd. DY received consulting or speaker fees from MSD K.K., Novo Nordisk Pharma Ltd. and Taisho Toyama Pharmaceutical Co. Ltd. D Yabe also received clinically commissioned/joint research grants from Taisho Toyama Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Co. Ltd. and Terumo Co. Ltd. AS received consulting or speaker fees from Asahi Kasei Pharma Co., Astellas Pharma Inc., Daiichi Sankyo Co, Ltd., Eli Lilly and Company., Mitsubishi Tanabe Pharma., MSD K.K., Pfizer, and Taisho Toyama Pharmaceutical Co. Ltd. AS received research support from Chugai Pharmaceutical Co. Ltd., MSD K.K., Ono Pharmaceuticals Co. Ltd. and Takeda Pharmaceutical Co. Ltd. Funding Information: YS received a scholarship grant from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (17k09823), Suzuken Memorial Foundation, Novo Nordisk Pharma Ltd., MSD K.K., Pfizer., Mitsubishi Tanabe Pharma., Eli Lilly and Company., Novartis Pharma., and Daiichi Sankyo Company Ltd. DY received consulting or speaker fees from MSD K.K., Novo Nordisk Pharma Ltd. and Taisho Toyama Pharmaceutical Co. Ltd. D Yabe also received clinically commissioned/joint research grants from Taisho Toyama Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Co. Ltd. and Terumo Co. Ltd. AS received consulting or speaker fees from Asahi Kasei Pharma Co., Astellas Pharma Inc., Daiichi Sankyo Co, Ltd., Eli Lilly and Company., Mitsubishi Tanabe Pharma., MSD K.K., Pfizer, and Taisho Toyama Pharmaceutical Co. Ltd. AS received research support from Chugai Pharmaceutical Co. Ltd., MSD K.K., Ono Pharmaceuticals Co. Ltd. and Takeda Pharmaceutical Co. Ltd.
PY - 2019/11/1
Y1 - 2019/11/1
UR - http://www.scopus.com/inward/record.url?scp=85074392698&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074392698&partnerID=8YFLogxK
U2 - 10.1111/jdi.13135
DO - 10.1111/jdi.13135
M3 - Article
C2 - 31472101
AN - SCOPUS:85074392698
VL - 10
SP - 1405
EP - 1407
JO - Journal of Diabetes Investigation
JF - Journal of Diabetes Investigation
SN - 2040-1116
IS - 6
ER -